BOSTON SCIENTIFIC CORP
Tremor tracks 2 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
- Announced layoffs or restructuringSince Jul 27, 2026+4.6
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 10 purchases
- Morano Susan EBoard member · Aug 25, 2026Bought 2,040 sharesabout $100 thousand ·
- Habiger David CBoard member · Aug 5, 2026Bought 2,100 sharesabout $100 thousand ·
- Habiger David CBoard member · Aug 4, 2026Bought 140 sharesabout $7 thousand ·
- Habiger David CBoard member · Aug 3, 2026Bought 1,042 sharesabout $50 thousand ·
- Mahoney Michael FChairman, President & CEO · Aug 3, 2026Bought 186,240 sharesabout $9.0 million ·
- LUDWIG EDWARD JBoard member · Jul 31, 2026
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.